Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ: MRVI )

5.950 +0.270 (+4.75%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Maravai LifeSciences Holdings, Inc. - Class A common stock

< Previous 1 2 Next >
Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors
Carl Hull to Retire as Executive Chairman 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Announces November 2024 Investor Conference Schedule
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research
From Maravai LifeSciences, Inc.
Via Business Wire
Maravai LifeSciences Reports Third Quarter 2024 Financial Results
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
TriLink BioTechnologies® & Alphazyme Collaborate to Launch New CleanScribe™ RNA Polymerase
From TriLink BioTechnologies
Via Business Wire
Cygnus Technologies and TriLink BioTechnologies® Collaborate to Launch AccuRes™ Host Cell DNA Quantification Kits
From TriLink BioTechnologies
Via Business Wire
Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Reports Second Quarter 2024 Financial Results
Continued Focus on Product Portfolio Expansion, Market Leadership and Scientific Innovation 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Appoints Trey Martin to Board of Directors
Maravai announces the appointment of CEO Trey Martin to its Board of Directors, highlighting his leadership, commitment to innovation, and industry experience 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai Lifesciences Releases 2023 Environmental, Social and Governance (ESG) Report
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
From TriLink BioTechnologies
Via Business Wire
Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Reports First Quarter 2024 Financial Results
Continued Focus on Product Portfolio Expansion, Market Leadership and Scientific Innovation 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
From TriLink BioTechnologies
Via Business Wire
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
From TriLink BioTechnologies
Via Business Wire
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Dyadic International Inc. (NASDAQ: DYAI) Funding to Propel Near-Term Revenue Growth Initiatives Highlights in Zacks Small-Cap Research Report
Via AB Newswire
Topics Regulatory Compliance
Exposures Legal Regulatory
Maravai LifeSciences Announces March 2024 Investor Conference Schedule
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Market Momentum: NASDAQ SmallCaps Sparking Waves in March 2024: CELZ, DYAI, GROM, VTAK, BREA
Via AB Newswire
Exposures Product Safety
Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS
Via AB Newswire
Healthcare Undervalued Opportunities Poised for Growth: DYAI, INBS, VTAK, RSCI, VERO, MRVI
Via AB Newswire
Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results
Continued Focus on Expanding Product Portfolio, Market Leadership and Innovation 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
TriLink BioTechnologies® Solidifies IP Position with Awarded Patents for CleanCap® Capping Technology in China and Canada
From TriLink BioTechnologies
Via Business Wire
Nasdaq Stocks Are Taking Center Stage This Week! DYAI, MRVI, SPWR, VTAK, KAVL, INBS
Via AB Newswire
Biopharmaceutical Advancements: Dyadic (Nasdaq: DYAI) Raises Industry Standards with Maravai LifeSciences’ (Nasdaq: MRVI) Cygnus Technologies
Via AB Newswire
Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing
From Dyadic International, Inc.
Via GlobeNewswire
Maravai LifeSciences To Host Earnings Conference Call on Thursday, February 22, 2024
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Announces November 2023 Investor Conference Schedule
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.